Disclosure submitted to exchange on April 2, 2025 and exchange email dated April 11, 2025
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals is re-submitting a disclosure originally filed on April 2, 2025, after the exchange flagged that it had been submitted under the wrong scrip code (106943 instead of 506943). The underlying announcement is the Board's approval to buy up to 70 lakh equity shares of Jamnagar Renewables One Private Limited (JROPL) at Rs. 10 each, aggregating up to Rs. 7 crore, from Continuum Green Energy Limited. JROPL is a newly set up special purpose vehicle building a 48.6 MW wind-solar hybrid power project in Jamnagar, Gujarat, and the stake will let JB Chemicals source captive renewable power for its plants, supporting its carbon-reduction and ESG goals. The transaction is in cash, is not a related-party deal, needs no regulatory approvals, and is expected to be completed by September 30, 2025. The acquisition gives JB Chemicals less than 4% shareholding in JROPL.
This is essentially a procedural re-filing correcting an earlier administrative error, so it carries no fresh market signal. The Rs. 7 crore investment is small and unlikely to affect the stock price, though it modestly supports long-term power-cost savings and the company's ESG profile.